ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION

Title:

ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION

Document Type and Number:

WIPO Patent Application WO/2021/030689

Kind Code:

A3

Abstract:

Embodiments of the invention generally fall into the category of activated thymulin synthesis and applications thereof. Embodiments, delivered orally or parenterally, are used to treat malignancies and immune system dysfunctions by activating cytotoxic T cells, increasing the generation of T helper 1 cells and/or boosting the production of interleukin 2.

More Like This:

JPH11171540	SPINEL TYPE MULTIPLE METAL OXIDE
JP2005145972	SOLID PHOTOPROTECTIVE COMPOSITION OBTAINED BY USING OCTENYLSUCCINIC ANHYDRIDE-ESTERIFIED STARCH SALT AS BASE AND USE OF THE SAME
JP2000136121	LIGHT-PROTECTING COSMETIC COMPOSITION AND ITS USE

Inventors:

PRASAD ANAND (US)
VARGHESE ROY (US)
BIRD PHILIP (US)
CLAYTON CHARLES (US)

Application Number:

PCT/US2020/046380

Publication Date:

March 18, 2021

Filing Date:

August 14, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CYTOLYF THERAPEUTICS LLC (US)

International Classes:

A61K8/27; C07K7/06; A61K38/08

Domestic Patent References:

WO2017210726A1

2017-12-14

Foreign References:

US4680276A	1987-07-14
US6840887B2	2005-01-11

Attorney, Agent or Firm:

ROMAGNANO, Joseph (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: IMMUNOSTIMULATORY MULTIMERIC BINDING MOLECULES

Next Patent: LOW-PRESSURE DEPOLYMERIZATION OF LIGNOCELLULOSIC BIOMASS